The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Knowing when to save money and when to invest is vital for financial success. This article provides insights on timing your decisions.
28,655 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Oil shocks tied to the Iran conflict threaten U.S. growth as prices rise. Analysts say a price threshold around $110 ...
Gusto, the San Francisco payroll and HR software group, confirms trailing revenue surpassing $1B as of February 2026,...
Pay transparency is surfacing a bigger problem: firms publish pay ranges but struggle to explain how they set actual ...
A 50-year-old couple with $1.1 million in retirement savings faces 15 years of growth and withdrawals. With $50,000 s...
The FDA recently approved fruit-flavored e-cigarettes, prompting scrutiny from health advocates and investors. A new ...
Pi Network launches two major Pi App Studio updates to boost persistence and AI-driven planning, even as PI token hit...
AI-driven capital spending and the wealth boost from tech stocks are accelerating U.S. GDP growth. Analysts say the d...
Ted Turner's open-loop model created the modern attention economy. This report analyzes its lasting impact on persona...
When Bam Margera was invited to the final Jackass premiere but won’t attend, it offers more than celebrity gossip. Th...
When spacex dipped below $150, the move drew attention from patient investors who study psychology, risk, and value. ...
As Cerebras moves toward its IPO, investors grapple with hype and reality. This guide breaks down what cerebras ipo: ...